semaglutide blindness risk Adults prescribed may have increased for form of optic neuropathy Wegovy linked to rare “eye

National Association of Insurance Commissioners

Treatment stage What may be common What deserves attention Week 1 Nausea, fullness, reduced appetite, bloating, indigestion, diarrhea, constipation, fatigue Repeated vomiting, severe pain, inability to stay hydrated Weeks 2 to 4 Early symptoms may settle, persist, or fluctuate Symptoms interfering with eating, drinking, or daily function Weeks 5 to 8 Symptoms may reappear after clinician-directed dose escalation A significant return or worsening of gastrointestinal symptoms Months 2 to 3 Some patients tolerate treatment more comfortably

Tirzepatide affects appetite-regulating hormones broadly, and a slow increase allows your bodys hunger and fullness signals to recalibrate gradually rather than getting overwhelmed all at once

Vaginal estrogen creams effectively treat atrophy-related spotting without significant systemic effects